Annual Working Capital
$77.86 M
-$80.49 M-50.83%
31 December 2023
Summary:
Adverum Biotechnologies annual working capital is currently $77.86 million, with the most recent change of -$80.49 million (-50.83%) on 31 December 2023. During the last 3 years, it has fallen by -$335.71 million (-81.17%). ADVM annual working capital is now -81.17% below its all-time high of $413.57 million, reached on 31 December 2020.ADVM Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$133.42 M
-$23.53 M-14.99%
30 September 2024
Summary:
Adverum Biotechnologies quarterly working capital is currently $133.42 million, with the most recent change of -$23.53 million (-14.99%) on 30 September 2024. Over the past year, it has increased by +$37.68 million (+39.36%). ADVM quarterly working capital is now -69.92% below its all-time high of $443.59 million, reached on 30 September 2020.ADVM Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.8% | +39.4% |
| 3 y3 years | -81.2% | -58.6% |
| 5 y5 years | -60.7% | -11.0% |
ADVM Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -81.2% | at low | -58.6% | +71.4% |
| 5 y | 5 years | -81.2% | at low | -69.9% | +71.4% |
| alltime | all time | -81.2% | >+9999.0% | -69.9% | >+9999.0% |
Adverum Biotechnologies Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $133.42 M(-15.0%) |
| June 2024 | - | $156.96 M(-11.6%) |
| Mar 2024 | - | $177.58 M(+128.1%) |
| Dec 2023 | $77.86 M(-50.8%) | $77.86 M(-18.7%) |
| Sept 2023 | - | $95.74 M(-6.7%) |
| June 2023 | - | $102.63 M(-16.2%) |
| Mar 2023 | - | $122.40 M(-22.7%) |
| Dec 2022 | $158.35 M(-46.5%) | $158.35 M(-14.2%) |
| Sept 2022 | - | $184.62 M(-14.3%) |
| June 2022 | - | $215.41 M(-16.1%) |
| Mar 2022 | - | $256.88 M(-13.2%) |
| Dec 2021 | $295.82 M(-28.5%) | $295.82 M(-8.3%) |
| Sept 2021 | - | $322.50 M(-11.8%) |
| June 2021 | - | $365.74 M(-6.2%) |
| Mar 2021 | - | $389.93 M(-5.7%) |
| Dec 2020 | $413.57 M(+164.3%) | $413.57 M(-6.8%) |
| Sept 2020 | - | $443.59 M(+69.7%) |
| June 2020 | - | $261.43 M(-7.8%) |
| Mar 2020 | - | $283.68 M(+81.3%) |
| Dec 2019 | $156.46 M | $156.46 M(+4.4%) |
| Sept 2019 | - | $149.86 M(-12.1%) |
| June 2019 | - | $170.41 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $182.53 M(-7.8%) |
| Dec 2018 | $198.03 M(+8.2%) | $198.03 M(-6.6%) |
| Sept 2018 | - | $212.11 M(-6.4%) |
| June 2018 | - | $226.55 M(-5.6%) |
| Mar 2018 | - | $239.92 M(+31.1%) |
| Dec 2017 | $183.07 M(-15.0%) | $183.07 M(+1.8%) |
| Sept 2017 | - | $179.91 M(-6.0%) |
| June 2017 | - | $191.33 M(-4.7%) |
| Mar 2017 | - | $200.67 M(-6.8%) |
| Dec 2016 | $215.38 M(-15.3%) | $215.38 M(-4.4%) |
| Sept 2016 | - | $225.25 M(-4.4%) |
| June 2016 | - | $235.67 M(-3.3%) |
| Mar 2016 | - | $243.67 M(-4.2%) |
| Dec 2015 | $254.42 M(+64.3%) | $254.42 M(-3.6%) |
| Sept 2015 | - | $263.87 M(-3.3%) |
| June 2015 | - | $272.77 M(-3.8%) |
| Mar 2015 | - | $283.50 M(+83.1%) |
| Dec 2014 | $154.81 M(<-9900.0%) | $154.81 M(-4.4%) |
| Sept 2014 | - | $161.87 M(+230.9%) |
| June 2014 | - | $48.91 M(-1.5%) |
| Mar 2014 | - | $49.66 M(<-9900.0%) |
| Dec 2013 | -$340.00 K(-25.6%) | -$340.00 K |
| Dec 2012 | -$457.00 K | - |
FAQ
- What is Adverum Biotechnologies annual working capital?
- What is the all time high annual working capital for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual working capital year-on-year change?
- What is Adverum Biotechnologies quarterly working capital?
- What is the all time high quarterly working capital for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly working capital year-on-year change?
What is Adverum Biotechnologies annual working capital?
The current annual working capital of ADVM is $77.86 M
What is the all time high annual working capital for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual working capital is $413.57 M
What is Adverum Biotechnologies annual working capital year-on-year change?
Over the past year, ADVM annual working capital has changed by -$80.49 M (-50.83%)
What is Adverum Biotechnologies quarterly working capital?
The current quarterly working capital of ADVM is $133.42 M
What is the all time high quarterly working capital for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly working capital is $443.59 M
What is Adverum Biotechnologies quarterly working capital year-on-year change?
Over the past year, ADVM quarterly working capital has changed by +$37.68 M (+39.36%)